Theragenics subsidiary Galt Medical said it has acquired Sligo, Ireland-based medtech development firm Arrotek Medical. Arrotek develops and designs minimally invasive medical devices supporting a range of catheter-based, interventional applications. Its capabilities include concept, design, product development, regulatory approval, and certain manufacturing services. Arrotek co-founders Mark Pugh and Ger O’Carroll will remain with the company in Sligo […]
Theragenics buys Eckert & Ziegler brachytherapy seed biz
Theragenics (NYSE:TGX) said today it picked up Eckert & Ziegler’s U.S. and Canadian brachytherapy seed business. Financial and other terms of the deal were not disclosed by the companies. The transaction closed on the end of last year, and included U.S. and Candian customers and the rights to EZB’s AnchorSeed, VariStrand and other seed products, […]
Theragenics to hire 50 in Costa Rica after cutting 139 in Texas
Surgical devices maker Theragenics is looking to add some employees overseas at it prepares to ramp up manufacturing at a new facility in Costa Rica, part of larger outsourcing plans that included cuts in the U.S.
Men are still in the dark about prostate cancer screening, Theragenics survey shows
M&A: Theragenics and Juniper make it official
Theragenics gives PE firm Juniper another week of exclusivity in buyout bid
It appears that Theragenics (NYSE:TGX) and Juniper Investment Co. need a little more time to hash out the details of an acquisition that has been valued at more than $70 million.
Medical device tax: Theragenics, layoffs and the essence of the fight for repeal
Report: Galt Medical’s Texas plant closure means 139 layoffs
Texas-based Galt Medical Corp., a division of Theragenics (NYSE:TGX), is laying off 139 employees as it closes doors on a facility in its Garland hometown, according to a notice filed with state authorities.
MassDevice.com +3 | The top 3 med-tech stories for May 13, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Theragenics soars on private equity buyout offer
Theragenics (NYSE:TGX) said a private equity firm, Juniper Investment Co., offered to pay up to roughly $71 million for the medical device company, sending its shares to a 52-week high today on Wall Street.
Johnson & Johnson hits 52-week high on boosted earnings forecast | Wall Street Beat
Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).